Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.
Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Cancer Lett. 2024 May 1;589:216827. doi: 10.1016/j.canlet.2024.216827. Epub 2024 Mar 23.
Lung cancer is the leading cause of cancer-related death worldwide; however, the mechanism of lung carcinogenesis has not been clearly defined. Chronic exposure to hexavalent chromium [Cr(VI)], a common environmental and occupational pollutant, causes lung cancer, representing an important lung cancer etiology factor. The mechanism of how chronic Cr(VI) exposure causes lung cancer remains largely unknown. By using cell culture and mouse models and bioinformatics analyses of human lung cancer gene expression profiles, this study investigated the mechanism of Cr(VI)-induced lung carcinogenesis. A new mouse model of Cr(VI)-induced lung carcinogenesis was developed as evidenced by the findings showing that a 16-week Cr(VI) exposure (CaCrO, 100 μg per mouse once per week) via oropharyngeal aspiration induced lung adenocarcinomas in male and female A/J mice, whereas none of the sham-exposed control mice had lung tumors. Mechanistic studies revealed that chronic Cr(VI) exposure activated the non-canonical NFκB pathway through the long non-coding RNA (lncRNA) ABHD11-AS1/deubiquitinase USP15-mediated tumor necrosis factor receptor-associated factor 3 (TRAF3) down-regulation. The non-canonical NFκB pathway activation increased the interleukin 6 (IL-6)/Janus kinase (Jak)/signal transducer and activator of transcription 3 (Stat3) signaling. The activation of the IL-6/Jak signaling axis by Cr(VI) exposure not only promoted inflammation but also stabilized the immune checkpoint molecule programmed death-ligand 1 (PD-L1) protein in the lungs, reducing T lymphocyte infiltration to the lungs. Given the well-recognized critical role of PD-L1 in inhibiting anti-tumor immunity, these findings suggested that the lncRNA ABHD11-AS1-mediated non-canonical NFκB pathway activation and PD-L1 up-regulation may play important roles in Cr(VI)-induced lung carcinogenesis.
肺癌是全球癌症相关死亡的主要原因;然而,肺癌的发病机制尚未明确。六价铬(Cr(VI))是一种常见的环境和职业污染物,慢性暴露于六价铬会导致肺癌,是重要的肺癌病因因素之一。慢性 Cr(VI)暴露如何导致肺癌的机制在很大程度上仍不清楚。本研究通过细胞培养和小鼠模型以及人类肺癌基因表达谱的生物信息学分析,研究了 Cr(VI)诱导肺癌发生的机制。通过发现经口吸入 16 周(CaCrO,每周每只小鼠 100μg)Cr(VI)暴露可诱导雄性和雌性 A/J 小鼠发生肺腺癌,从而建立了 Cr(VI)诱导肺癌发生的新小鼠模型,而假暴露对照小鼠均未发生肺肿瘤。机制研究表明,慢性 Cr(VI)暴露通过长链非编码 RNA(lncRNA)ABHD11-AS1/去泛素化酶 USP15 介导的肿瘤坏死因子受体相关因子 3(TRAF3)下调激活非经典 NFκB 通路。非经典 NFκB 通路的激活增加了白细胞介素 6(IL-6)/Janus 激酶(Jak)/信号转导和转录激活因子 3(Stat3)信号。Cr(VI)暴露激活的 IL-6/Jak 信号轴不仅促进炎症,而且稳定肺部免疫检查点分子程序性死亡配体 1(PD-L1)蛋白,减少 T 淋巴细胞浸润肺部。鉴于 PD-L1 在抑制抗肿瘤免疫中的公认关键作用,这些发现表明 lncRNA ABHD11-AS1 介导的非经典 NFκB 通路激活和 PD-L1 上调可能在 Cr(VI)诱导的肺癌发生中发挥重要作用。